Concord Medical Services Holdings Limited (CCM) reported CN¥460.51M of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 19.9% from the year before.

No. Concord Medical Services Holdings Limited reported a net loss of CN¥92.81M for fiscal 2025 (ended Dec 31, 2025).

How much cash and debt does CCM have?

Concord Medical Services Holdings Limited reported CN¥297.79M in cash and cash equivalents and CN¥3.45B of debt on its most recent balance sheet in SEC filings.

How fast is CCM revenue growing?

Concord Medical Services Holdings Limited's revenue changed +19.9% in fiscal 2025, to CN¥460.51M. Its compound annual growth rate was +15.6% over 5 years and -2.9% over 10 years.

What is CCM gross margin?

Concord Medical Services Holdings Limited's gross profit was CN¥25.82M on CN¥460.51M of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of 5.6%.

What is CCM free cash flow?

Concord Medical Services Holdings Limited generated -CN¥258.15M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -CN¥201.82M less capital expenditures.

What is CCM earnings per share?

Diluted earnings per share were -CN¥0.71 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.

When did CCM last report financial results?

The latest statements here come from Concord Medical Services Holdings Limited's 20-F filed on Apr 29, 2026, covering the period ended Dec 31, 2025.

Financials · CCM

Concord Medical Services Holdings Limited (CCM) financials

For fiscal 2025 (ended Dec 31, 2025), Concord Medical Services Holdings Limited reported CN¥460.51M of revenue and -CN¥92.81M of net income. Figures are in CNY, the currency of its SEC filings.

Revenue, FY2025: CN¥460.51M
Revenue growth, YoY: +19.9%
Net income, FY2025: -CN¥92.81M
Net margin: -20.2%
Free cash flow, FY2025: -CN¥258.15M
EPS, diluted, FY2025: -CN¥0.71
Cash: CN¥297.79M
Total debt: CN¥3.45B

Annual revenueCN¥460.51M

FY2016FY2025

Annual net income-CN¥92.81M

FY2016FY2025

Annual free cash flow-CN¥258.15M

FY2016FY2025

CCM revenue and earnings growth

CCM revenueFY2025CN¥460.51M

FY YoY: +19.9%
5Y CAGR: +15.6%
10Y CAGR: -2.9%

CCM revenue was CN¥460.51M for fiscal 2025 (ended Dec 31, 2025), up 19.9% from fiscal 2024. Compound annual growth was +15.6% over 5 years and -2.9% over 10 years. It rose in 5 of the last 10 fiscal years.

CCM net incomeFY2025-CN¥92.81M

CCM net income was -CN¥92.81M for fiscal 2025 (ended Dec 31, 2025), compared with -CN¥308.24M in fiscal 2024.

CCM EPSFY2025-CN¥0.71

CCM diluted EPS was -CN¥0.71 for fiscal 2025 (ended Dec 31, 2025), compared with -CN¥2.35 in fiscal 2024.

CCM free cash flowFY2025-CN¥258.15M

CCM free cash flow was -CN¥258.15M for fiscal 2025 (ended Dec 31, 2025), compared with -CN¥548.52M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	CN¥460.51M	CN¥383.96M	CN¥537.40M	CN¥472.08M	CN¥485.63M	CN¥223.01M	CN¥198.36M	CN¥190.90M	CN¥330.98M	CN¥455.04M
Cost of revenue	CN¥434.69M	CN¥463.12M	CN¥614.01M	CN¥624.49M	CN¥542.53M	CN¥209.93M	CN¥214.19M	CN¥171.14M	CN¥232.98M	CN¥286.54M
Gross profit	CN¥25.82M	-CN¥79.16M	-CN¥76.61M	-CN¥152.41M	-CN¥56.90M	CN¥13.08M	-CN¥15.83M	CN¥19.76M	CN¥98.00M	CN¥168.50M
Selling, general and admin	CN¥212.97M	CN¥404.37M	CN¥330.08M	CN¥311.16M	CN¥347.75M	CN¥294.82M	CN¥315.13M	CN¥291.85M	CN¥237.65M	CN¥205.91M
Operating income	-CN¥261.49M	-CN¥532.16M	-CN¥462.99M	-CN¥525.05M	-CN¥458.32M	-CN¥316.00M	-CN¥437.29M	-CN¥299.24M	-CN¥211.86M	-CN¥168.63M
Interest expense	CN¥152.33M	CN¥193.20M	CN¥165.67M	CN¥120.36M	CN¥73.79M	CN¥81.36M	CN¥28.70M	CN¥46.23M	CN¥89.96M	CN¥89.33M
Pre-tax income	-CN¥373.36M	-CN¥669.58M	-CN¥555.59M	-CN¥839.90M	CN¥529.24M	CN¥441.65M	CN¥391.08M	CN¥225.25M	CN¥253.90M	CN¥204.60M
Income tax	CN¥6.06M	-CN¥17.50M	-CN¥24.57M	-CN¥70.91M	-CN¥6.57M	-CN¥37.62M	-CN¥38.99M	CN¥34.05M	CN¥31.79M	CN¥60.49M
Net income	-CN¥92.81M	-CN¥308.24M	-CN¥297.66M	-CN¥489.66M	-CN¥271.43M	-CN¥309.99M	-CN¥307.05M	-CN¥234.88M	-CN¥284.32M	-CN¥261.87M
EPS, basic	-CN¥0.71	-CN¥2.35	-CN¥2.27	-CN¥3.74	-CN¥6.26	-CN¥5.11	-CN¥4.24	-CN¥2.76	-CN¥2.19	-CN¥2.00
EPS, diluted	-CN¥0.71	-CN¥2.35	-CN¥2.27	-CN¥3.74	-CN¥6.26	-CN¥5.11	-CN¥4.24	-CN¥2.76	-CN¥2.19	-CN¥2.00
Diluted shares	131.1M	131.1M	131.1M	131.1M	131.1M	131.1M	130.2M	130.1M	130.1M	130.6M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	CN¥297.79M	CN¥216.22M	CN¥58.14M	CN¥159.34M	CN¥158.91M	CN¥446.39M	CN¥74.31M	CN¥826.73M	CN¥662.18M	CN¥758.40M
Short-term investments	CN¥1.0K	CN¥134.62M	-	-	-	-	CN¥0	CN¥50.00M	CN¥0	-
Receivables	CN¥44.05M	CN¥51.17M	CN¥73.50M	CN¥130.27M	CN¥127.90M	CN¥77.38M	CN¥73.73M	CN¥86.87M	CN¥131.95M	CN¥189.59M
Inventory	CN¥45.97M	CN¥33.44M	CN¥40.35M	CN¥84.83M	CN¥38.09M	CN¥21.61M	CN¥4.34M	CN¥3.36M	CN¥6.28M	CN¥5.92M
Current assets	CN¥941.91M	CN¥983.97M	CN¥617.21M	CN¥759.80M	CN¥584.48M	CN¥676.00M	CN¥282.49M	CN¥1.23B	CN¥1.11B	CN¥1.19B
Goodwill	CN¥572.22M	CN¥572.22M	CN¥575.43M	CN¥575.43M	CN¥581.88M	CN¥213.66M	CN¥210.44M	CN¥165.17M	-	-
Total assets	CN¥6.55B	CN¥6.73B	CN¥6.05B	CN¥6.00B	CN¥6.23B	CN¥5.33B	CN¥4.30B	CN¥4.59B	CN¥3.47B	CN¥3.23B
Current liabilities	CN¥1.95B	CN¥2.13B	CN¥1.95B	CN¥1.12B	CN¥804.52M	CN¥512.12M	CN¥627.45M	CN¥870.26M	CN¥1.11B	CN¥951.06M
Short-term debt	CN¥981.06M	CN¥1.03B	CN¥1.04B	CN¥512.58M	CN¥299.35M	CN¥148.88M	CN¥328.44M	CN¥440.59M	CN¥709.36M	CN¥645.00M
Long-term debt	CN¥2.47B	CN¥2.69B	CN¥1.99B	CN¥2.47B	CN¥2.18B	CN¥1.97B	CN¥1.29B	CN¥497.53M	CN¥284.58M	CN¥215.67M
Total debt	CN¥3.45B	CN¥3.73B	CN¥3.04B	CN¥2.98B	CN¥2.48B	CN¥2.12B	CN¥1.62B	CN¥938.11M	CN¥993.95M	CN¥860.67M
Total liabilities	CN¥4.70B	CN¥5.11B	CN¥4.31B	CN¥3.99B	CN¥3.49B	CN¥2.93B	CN¥2.41B	CN¥2.31B	CN¥2.45B	CN¥2.00B
Shareholders' equity	-CN¥2.10B	-CN¥2.28B	CN¥1.75B	CN¥2.02B	-CN¥937.06M	-CN¥512.85M	-CN¥20.37M	CN¥553.51M	CN¥1.01B	CN¥1.23B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	-CN¥201.82M	-CN¥397.75M	-CN¥276.47M	-CN¥216.69M	-CN¥359.31M	-CN¥229.77M	-CN¥195.35M	-CN¥38.59M	CN¥26.73M	-CN¥78.08M
Capital expenditures	CN¥56.32M	CN¥150.77M	CN¥113.00M	CN¥222.98M	CN¥278.98M	CN¥168.02M	CN¥232.69M	CN¥165.60M	CN¥91.26M	CN¥78.92M
Free cash flow	-CN¥258.15M	-CN¥548.52M	-CN¥389.47M	-CN¥439.67M	-CN¥638.29M	-CN¥397.79M	-CN¥428.04M	-CN¥204.19M	-CN¥64.53M	-CN¥157.00M
Investing cash flow	CN¥53.97M	-CN¥593.44M	-CN¥47.68M	-CN¥118.79M	-CN¥565.98M	-CN¥533.88M	-CN¥1.07B	-CN¥1.00B	-CN¥313.01M	-CN¥74.85M
Financing cash flow	CN¥197.23M	CN¥1.15B	CN¥257.65M	CN¥383.09M	CN¥642.45M	CN¥1.14B	CN¥513.27M	CN¥1.20B	CN¥189.90M	-CN¥117.92M
Dividends paid	-	-	-	-	-	-	-	CN¥0	CN¥0	CN¥285.83M
Share repurchases	-	-	-	-	-	-	-	CN¥0	CN¥0	CN¥30.40M
Stock-based compensation	-	-	CN¥0	-CN¥5.92M	CN¥14.68M	CN¥20.62M	CN¥20.59M	CN¥11.14M	CN¥11.64M	CN¥8.40M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	19.9%	-28.6%	13.8%	-2.8%	117.8%	12.4%	3.9%	-42.3%	-27.3%	-26.2%
Gross margin	5.6%	-20.6%	-14.3%	-32.3%	-11.7%	5.9%	-8.0%	10.4%	29.6%	37.0%
Operating margin	-56.8%	-138.6%	-86.2%	-111.2%	-94.4%	-141.7%	-220.5%	-156.8%	-64.0%	-37.1%
Net margin	-20.2%	-80.3%	-55.4%	-103.7%	-55.9%	-139.0%	-154.8%	-123.0%	-85.9%	-57.5%
Free cash flow margin	-56.1%	-142.9%	-72.5%	-93.1%	-131.4%	-178.4%	-215.8%	-107.0%	-19.5%	-34.5%
Return on equity	-	-	-17.0%	-24.3%	-	-	-	-42.4%	-28.0%	-21.3%
Return on assets	-1.4%	-4.6%	-4.9%	-8.2%	-4.4%	-5.8%	-7.1%	-5.1%	-8.2%	-8.1%
Current ratio	0.48	0.46	0.32	0.68	0.73	1.32	0.45	1.41	1.00	1.26
Debt to equity	-	-	1.74	1.48	-	-	-	1.69	0.98	0.70

Source: XBRL data Concord Medical Services Holdings Limited files with the SEC, latest filing dated Apr 29, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.

CCM peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CCM	CN¥460.51M	+19.9%	-CN¥92.81M	-20.2%	$16.1M
BTSGBrightSpring Health Services Inc.	$15.25B	+26.0%	$410.27M	2.7%	$13.36B
CHEChemed Corp	$2.66B	+5.2%	$282.40M	10.6%	$6.87B
HIMSHims & Hers Health Inc.	$2.58B	+28.0%	-$142.03M	-5.5%	$6.06B
LFSTLifeStance Health Group Inc.	$1.68B	+22.6%	$71.91M	4.3%	$5.26B
OPCHOption Care Health Inc.	$5.75B	+4.0%	$215.19M	3.7%	$4.74B
PRVAPrivia Health Group Inc.	$2.43B	+19.2%	$36.08M	1.5%	$3.12B
AVAHAveanna Healthcare Holdings Inc.	$2.60B	+19.5%	$274.76M	10.6%	$2.89B
ADUSAddus HomeCare Corporation	$1.50B	+11.5%	$111.05M	7.4%	$2.32B

CCM FAQ

9 questions

What is CCM revenue?
Concord Medical Services Holdings Limited (CCM) reported CN¥460.51M of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 19.9% from the year before.
Is CCM profitable?
No. Concord Medical Services Holdings Limited reported a net loss of CN¥92.81M for fiscal 2025 (ended Dec 31, 2025).
How much cash and debt does CCM have?
Concord Medical Services Holdings Limited reported CN¥297.79M in cash and cash equivalents and CN¥3.45B of debt on its most recent balance sheet in SEC filings.
How fast is CCM revenue growing?
Concord Medical Services Holdings Limited's revenue changed +19.9% in fiscal 2025, to CN¥460.51M. Its compound annual growth rate was +15.6% over 5 years and -2.9% over 10 years.
What is CCM gross margin?
Concord Medical Services Holdings Limited's gross profit was CN¥25.82M on CN¥460.51M of revenue for fiscal 2025 (ended Dec 31, 2025), a gross margin of 5.6%.
What is CCM free cash flow?
Concord Medical Services Holdings Limited generated -CN¥258.15M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -CN¥201.82M less capital expenditures.
What is CCM earnings per share?
Diluted earnings per share were -CN¥0.71 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.
When did CCM last report financial results?
The latest statements here come from Concord Medical Services Holdings Limited's 20-F filed on Apr 29, 2026, covering the period ended Dec 31, 2025.
Where does this CCM financial data come from?
Quantisnow builds these statements from the structured XBRL data Concord Medical Services Holdings Limited files with the SEC. It is provided for information only and is not investment advice.